PublizoomAward notice Supplies
paliperidone IM en PO
Notice published in Dutch. The AI analysis summarises it for you in your language.
- Public buyer
- EMMAUS VZW
Mechelen - Place of performance
- 2800 Mechelen, Antwerp
- Amount awarded
- €227,000 excl. VAT
- Planned end of contract
- 14 November 2028
likely re-tender around May 2028 - Bids received
- 1
- Form
- Framework agreement
Multi-year contract: the buyer places orders as needs arise. - Procedure
- Open procedure
Any company may submit a bid. - Publication
- 4 June 2025
- Notice language
- Dutch
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
paliperidone IM en PO
Awarded to
- AREGA PHARMA BVBA BCE/KBO 0722.544.585
2 lots
- paliperidone IV
- paliperidone PO
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33690000
Winning prices for comparable contracts
- A quarter below
- €444,216
- Median
- €606,904
- A quarter above
- €1,514,536
Amounts awarded (excl. VAT) over the last 3 years for 27 contracts in the same CPV group (3369…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| Contraststoffen EMMAUS VZW · 4 June 2025 |
Bracco BAYER NV GE HEALTHCARE GUERBET SA |
€4,837,000 |
| Aqua voor injectie, NaCl 0.9%, andere miniplasco's en magnesiumsulfaat EMMAUS VZW · 4 June 2025 |
B. Braun Medical nv Grindeks Kalceks Belgium |
€1,880,000 |
| Diverse geneesmiddelen oncologie PO voor Helixziekenhuizen EMMAUS VZW · 4 June 2025 |
EUROGENERICS SA Novartis Pharma PFIZER SA Accord Healthcare BV SANDOZ NV AREGA PHARMA BVBA Mylan EPD (Entiteit van Viatris) |
€874,780 |
| Aankoop en installatie van een immuunhematologie configuratie , met reagentia en onderhoud EMMAUS VZW · 3 June 2025 |
ORTHO-CLINICAL DIAGNOSTICS NV | €700,000 |
| Pantoprazol (IV en PO) - Esomeprazol PO - Ondansetron IV - Palonosetron IV EMMAUS VZW · 4 December 2024 |
AREGA PHARMA BVBA FRESENIUS KABI NV |
€236,832 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 359784-2025.